Recurrent autoimmune inner ear disease (AIED) and polyarteritis nodosa in a patient with large cell lung carcinoma

Hsien Tzung Liao, Chih Hung Chien, Chung Hsiung Chen, Hon Pin Wang, De Feng Huang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Autoimmune inner ear disease (AIED) is a very rare disorder with distinct clinical features and can occur in patients with malignancy or autoimmune diseases. We report a 72-year-old male patient with polyarteritis nodosa treated continuously for 5 years with aggressive immunosuppressive drugs, including cyclophosphamide, who experienced three episodes of acute hearing loss during treatment. Organic lesions of the external and middle ear were excluded by repeated examinations, and if one subscribes to McCabe's (Ann Otol Rhinol Laryngol 88:585-589, 1979) definition of AIED, this condition must be considered as the likely cause of the hearing loss. During the period of treatment, three episodes of AIED occurred, and eventually, lung cancer developed. From the time relationship and clinical manifestations of neuropathy and livedo reticularis, the first episode of hearing loss was more likely to be related to vasculitis itself, while the third episode may well have been associated with the development of lung cancer given the dramatic improvement in the clinical condition following treatment of the tumor by excision and cancer chemotherapy. Coexistence of AIED, vasculitis, and malignancy in the same patient has only been reported infrequently, and our case suggests that this coexistence may not be coincidental. For those patients with autoimmune disease who are on long-term immunosuppressive drug therapy, active surveillance for a nascent malignant tumor should be exercised if AIED recurs or persists.

Original languageEnglish
Pages (from-to)1008-1010
Number of pages3
JournalClinical Rheumatology
Volume26
Issue number6
DOIs
Publication statusPublished - Jun 2007

Fingerprint

Labyrinth Diseases
Large Cell Carcinoma
Polyarteritis Nodosa
Lung
Hearing Loss
Neoplasms
Immunosuppressive Agents
Vasculitis
Autoimmune Diseases
Lung Neoplasms
Livedo Reticularis
External Ear
Drug Therapy
Middle Ear
Cyclophosphamide
Therapeutics
Pharmaceutical Preparations

Keywords

  • Autoimmune inner ear disease (AIED)
  • Livedo reticularis
  • Malignancy
  • Mononeuritis multiplex
  • Vasculitis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Recurrent autoimmune inner ear disease (AIED) and polyarteritis nodosa in a patient with large cell lung carcinoma. / Liao, Hsien Tzung; Chien, Chih Hung; Chen, Chung Hsiung; Wang, Hon Pin; Huang, De Feng.

In: Clinical Rheumatology, Vol. 26, No. 6, 06.2007, p. 1008-1010.

Research output: Contribution to journalArticle

Liao, Hsien Tzung ; Chien, Chih Hung ; Chen, Chung Hsiung ; Wang, Hon Pin ; Huang, De Feng. / Recurrent autoimmune inner ear disease (AIED) and polyarteritis nodosa in a patient with large cell lung carcinoma. In: Clinical Rheumatology. 2007 ; Vol. 26, No. 6. pp. 1008-1010.
@article{fc1fe1992d9b4a7eaa398714caabadc6,
title = "Recurrent autoimmune inner ear disease (AIED) and polyarteritis nodosa in a patient with large cell lung carcinoma",
abstract = "Autoimmune inner ear disease (AIED) is a very rare disorder with distinct clinical features and can occur in patients with malignancy or autoimmune diseases. We report a 72-year-old male patient with polyarteritis nodosa treated continuously for 5 years with aggressive immunosuppressive drugs, including cyclophosphamide, who experienced three episodes of acute hearing loss during treatment. Organic lesions of the external and middle ear were excluded by repeated examinations, and if one subscribes to McCabe's (Ann Otol Rhinol Laryngol 88:585-589, 1979) definition of AIED, this condition must be considered as the likely cause of the hearing loss. During the period of treatment, three episodes of AIED occurred, and eventually, lung cancer developed. From the time relationship and clinical manifestations of neuropathy and livedo reticularis, the first episode of hearing loss was more likely to be related to vasculitis itself, while the third episode may well have been associated with the development of lung cancer given the dramatic improvement in the clinical condition following treatment of the tumor by excision and cancer chemotherapy. Coexistence of AIED, vasculitis, and malignancy in the same patient has only been reported infrequently, and our case suggests that this coexistence may not be coincidental. For those patients with autoimmune disease who are on long-term immunosuppressive drug therapy, active surveillance for a nascent malignant tumor should be exercised if AIED recurs or persists.",
keywords = "Autoimmune inner ear disease (AIED), Livedo reticularis, Malignancy, Mononeuritis multiplex, Vasculitis",
author = "Liao, {Hsien Tzung} and Chien, {Chih Hung} and Chen, {Chung Hsiung} and Wang, {Hon Pin} and Huang, {De Feng}",
year = "2007",
month = "6",
doi = "10.1007/s10067-006-0250-1",
language = "English",
volume = "26",
pages = "1008--1010",
journal = "Clinical Rheumatology",
issn = "0770-3198",
publisher = "Springer London",
number = "6",

}

TY - JOUR

T1 - Recurrent autoimmune inner ear disease (AIED) and polyarteritis nodosa in a patient with large cell lung carcinoma

AU - Liao, Hsien Tzung

AU - Chien, Chih Hung

AU - Chen, Chung Hsiung

AU - Wang, Hon Pin

AU - Huang, De Feng

PY - 2007/6

Y1 - 2007/6

N2 - Autoimmune inner ear disease (AIED) is a very rare disorder with distinct clinical features and can occur in patients with malignancy or autoimmune diseases. We report a 72-year-old male patient with polyarteritis nodosa treated continuously for 5 years with aggressive immunosuppressive drugs, including cyclophosphamide, who experienced three episodes of acute hearing loss during treatment. Organic lesions of the external and middle ear were excluded by repeated examinations, and if one subscribes to McCabe's (Ann Otol Rhinol Laryngol 88:585-589, 1979) definition of AIED, this condition must be considered as the likely cause of the hearing loss. During the period of treatment, three episodes of AIED occurred, and eventually, lung cancer developed. From the time relationship and clinical manifestations of neuropathy and livedo reticularis, the first episode of hearing loss was more likely to be related to vasculitis itself, while the third episode may well have been associated with the development of lung cancer given the dramatic improvement in the clinical condition following treatment of the tumor by excision and cancer chemotherapy. Coexistence of AIED, vasculitis, and malignancy in the same patient has only been reported infrequently, and our case suggests that this coexistence may not be coincidental. For those patients with autoimmune disease who are on long-term immunosuppressive drug therapy, active surveillance for a nascent malignant tumor should be exercised if AIED recurs or persists.

AB - Autoimmune inner ear disease (AIED) is a very rare disorder with distinct clinical features and can occur in patients with malignancy or autoimmune diseases. We report a 72-year-old male patient with polyarteritis nodosa treated continuously for 5 years with aggressive immunosuppressive drugs, including cyclophosphamide, who experienced three episodes of acute hearing loss during treatment. Organic lesions of the external and middle ear were excluded by repeated examinations, and if one subscribes to McCabe's (Ann Otol Rhinol Laryngol 88:585-589, 1979) definition of AIED, this condition must be considered as the likely cause of the hearing loss. During the period of treatment, three episodes of AIED occurred, and eventually, lung cancer developed. From the time relationship and clinical manifestations of neuropathy and livedo reticularis, the first episode of hearing loss was more likely to be related to vasculitis itself, while the third episode may well have been associated with the development of lung cancer given the dramatic improvement in the clinical condition following treatment of the tumor by excision and cancer chemotherapy. Coexistence of AIED, vasculitis, and malignancy in the same patient has only been reported infrequently, and our case suggests that this coexistence may not be coincidental. For those patients with autoimmune disease who are on long-term immunosuppressive drug therapy, active surveillance for a nascent malignant tumor should be exercised if AIED recurs or persists.

KW - Autoimmune inner ear disease (AIED)

KW - Livedo reticularis

KW - Malignancy

KW - Mononeuritis multiplex

KW - Vasculitis

UR - http://www.scopus.com/inward/record.url?scp=34250703839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250703839&partnerID=8YFLogxK

U2 - 10.1007/s10067-006-0250-1

DO - 10.1007/s10067-006-0250-1

M3 - Article

C2 - 16552463

AN - SCOPUS:34250703839

VL - 26

SP - 1008

EP - 1010

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 0770-3198

IS - 6

ER -